Publicaciones originales en revistas revisadas por pares (Peer-reviewed Journals)

1. Gutarra‐Vilchez  RB, Vazquez JC, Glujovsky  D, Lizaraso F, Viteri‐García  A, Martinez‐Zapata  MJ. Vasodilators for women undergoing fertility treatment. Cochrane Database of Systematic Reviews 2025 Mar 6;3(3):CD010001. doi: 10.1002/14651858.CD010001.pub4.
2. Glujovsky D, Quinteiro Retamar AM, Alvarez Sedo CR, Ciapponi A, Cornelisse S, Blake D. Cleavage‐stage versus blastocyst‐stage embryo transfer in assisted reproductive technology. Cochrane Database of Systematic Reviews 2022, Issue 5. Art. No.: CD002118. DOI: 10.1002/14651858.CD002118.pub6.
3. Gleicher N, Barad DH, Ben-Rafael Z, Glujovsky D et al. Commentary on two recently published formal guidelines on management of “mosaic” embryos after preimplantation genetic testing for aneuploidy (PGT-A). Reprod Biol Endocrinol 19, 23 (2021). https://doi.org/10.1186/s12958-021-00716-1
4. Glujovsky D, Pesce R, Miguens M, Sueldo C, Lattes K, Ciapponi. How effective are the non-conventional ovarian stimulation protocols in ART? A systematic review and meta-analysis. J Assist Reprod Genet. 2020 Dec;37(12):2913-2928. https://doi.org/10.1007/s10815-020-01966-5
5. Glujovsky D, Pesce R, Sueldo C, Quinteiro Retamar AM, Hart RJ, Ciapponi A. Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes. Cochrane Database of Systematic Reviews 2020, Issue 10. Art. No.: CD006359. DOI: 10.1002/14651858.CD006359.pub3
6. Glujovsky, D., Sueldo, C.E., Bardach, A. et al. Quality of evidence matters: is it well reported and interpreted in infertility journals? J Assist Reprod Genet 37, 263–268 (2020).
7. Ciapponi A, Bardach A, Rey Ares L, Glujovsky D, Cafferata ML, Cesaroni S, Bhatti A. Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis. Cochrane Database of Systematic Reviews 2019, Issue 12. Art. No.:
   CD011260. DOI: 10.1002/14651858.CD011260.pub2
8. Duffy JMN, AlAhwany H, Bhattacharya S, Collura B, Curtis C, Evers JLH, Farquharson RG, Franik S, Giudice LC, Khalaf Y, Knijnenburg JML, Leeners B, Legro RS, Lensen S, Vazquez-Niebla JC, Mavrelos D, Mol BWJ, Niederberger C, Ng EHY, Otter AS, Puscasiu L, Rautakallio-Hokkanen S, Repping S, Sarris I, Simpson JL, Strandell A, Strawbridge C, Torrance HL, Vail A, van Wely M, Vercoe MA, Vuong NL, Wang AY, Wang R, Wilkinson J, Youssef MA, Farquhar CM; Core Outcome Measure for Infertility Trials (COMMIT) initiative. Developing a core outcome set for future infertility research: an international consensus development study. Hum Reprod. 2020 Dec 1;35(12):2725-2734. (contributor information – mentioned in the paper)
9. Lepine  S, McDowell  S, Searle  LM, Kroon  B, Glujovsky  D, Yazdani  A. Advanced sperm selection techniques for assisted reproduction. Cochrane Database of Systematic Reviews 2019, Issue 7. Art. No.: CD010461. DOI: 10.1002/14651858.CD010461.pub3
10. Gutarra‐Vilchez RB, Bonfill Cosp X, Glujovsky D, Viteri‐García A, Runzer‐Colmenares FM, Martinez‐Zapata MJ. Vasodilators for women undergoing fertility treatment. Cochrane Database of Systematic Reviews 2018, Issue 10. Art. No.: CD010001. DOI: 10.1002/14651858.CD010001.pub3
11. Glujovsky D, Sueldo CE, Coscia A, De Carvalho P, Lancuba S, Martinez G, Ciapponi A. Physicians and patients’ motivations to perform elective single or double-embryo transfers: A nationwide survey. Patient Educ Couns. 2017 Dec 12
12. Ciapponi A, Glujovsky D, Virgilio SA, Bardach AE. Conducting and Disseminating Epidemiological Systematic Reviews in Latin America and the Caribbean: Pitfalls and Lessons Learned. Value in Health Regional Issues. 2017;14:64-72.
13. Ciapponi A, Lee A, Bardach A, Glujovsky D, Rey-Ares L, Luisa Cafferata M, Valanzasca P, García Martí S. Interchangeability between Pneumococcal Conjugate Vaccines: A Systematic Review and Meta-Analysis. Value Health Reg Issues. 2016 Dec;11:24-34
14. Glujovsky D, Farquhar C. Cleavage-stage or blastocyst transfer: what are the benefits and harms? Fertil Steril 2016;106:244-50.
15. Glujovsky D, Farquhar C, Quinteiro Retamar AM, Alvarez Sedo CR, Blake D. Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology. Cochrane Database of Systematic Reviews 2016, Issue 6. Art. No.: CD002118. DOI: 10.1002/14651858.CD002118.pub5.
16. Glujovsky D, Sueldo CE, Borghi C, Nicotra P, Andreucci S, Ciapponi A. Misleading reporting and interpretation of results in major infertility journals. Fertil Steril 2016;105:1301-6.
17. Elena HE, Elena AF, Miola A, Glujovsky D, Sueldo CE. [Successful treatment of a cervical heterotopic pregnancy following an in vitro fertilization procedure]. Medicina (B Aires) 2016;76:30-2.
18. Pichon-Riviere A, Glujovsky D, Garay OU, Augustovski F, Ciapponi A, Serpa M, et al. Oxytocin in Uniject Disposable Auto-Disable Injection System versus Standard Use for the Prevention of Postpartum Hemorrhage in Latin America and the Caribbean: A Cost-Effectiveness Analysis. PLoS One. 2015;10(6):1-18.
19. Glujovsky D, Boggino C, Riestra B, Coscia A, Sueldo CE, Ciapponi A. Quality of reporting in infertility journals. Fertil Steril 2015;103:236-41.
20. Siristatidis C, Vrachnis N, Vogiatzi P, Chrelias C, Retamar AQ, Bettocchi S et al. Potential Pathophysiological Mechanisms of the Beneficial Role of Endometrial Injury in In Vitro Fertilization Outcome. Reproductive sciences 2014;21:955-65.
21. McDowell S, Kroon B, Ford E, Hook Y, Glujovsky D, Yazdani A. Advanced sperm selection techniques for assisted reproduction. Cochrane Database Syst Rev 2014;10:CD010461.
22. Glujovsky D, Villanueva E, Reveiz L, Murasaki R. [Adherence to research reporting guidelines in biomedical journals in Latin America and the Caribbean]. Rev Panam Salud Publica 2014;36:232-7.
23. Glujovsky D, Riestra B, Sueldo C, Fiszbajn G, Repping S, Nodar F et al. Vitrification versus slow freezing for women undergoing oocyte cryopreservation. Cochrane Database Syst Rev 2014;9:CD010047.
24. Siristatidis C, Vogiatzi P, Salamalekis G, Creatsa M, Vrachnis N, Glujovsky D et al. Granulocyte macrophage colony stimulating factor supplementation in culture media for subfertile women undergoing assisted reproduction technologies: a systematic review. International journal of endocrinology 2013;2013:704967.
25. Garcia Marti S, Pichon-Riviere A, Aruj P, Glujovsky D, Bardach A and Rodríguez A. Audit of the Coverage Decision-Making Process in a Government Agency in Uruguay: From the Guidelines Till the Patients. Value in Health 2013; 16(7):A674.
26. Savy V, Ciapponi A, Bardach A, Glujovsky D, Aruj P, Mazzoni A et al. Burden of influenza in Latin America and the Caribbean: a systematic review and meta-analysis. Influenza and other respiratory viruses 2013;7:1017-32.
27. Reveiz L, Sangalang S, Glujovsky D, Pinzon CE, Asenjo Lobos C, Cortes M et al. Characteristics of randomized trials published in Latin America and the Caribbean according to funding source. PLoS One 2013;8:e56410.
28. Glujovsky D, Ciapponi A. Reply of the authors to Drs. Siristatidis and Chrelias. Fertil Steril 2013;99:e13.
29. Alonso-Coello P, Carrasco-Labra A, Brignardello-Petersen R, Neumann I, Akl EA, Sun X et al. A methodological survey of the analysis, reporting and interpretation of Absolute Risk ReductiOn in systematic revieWs (ARROW): a study protocol. Systematic reviews 2013;2:113.
30. Reveiz L, Bonfill X, Glujovsky D, Pinzon CE, Asenjo-Lobos C, Cortes M et al. Trial registration in Latin America and the Caribbean’s: study of randomized trials published in 2010. J Clin Epidemiol 2012;65:482-7.
31. Glujovsky D, Riestra B, Coscia A, Boggino C, Comande D, Ciapponi A. Assessment of research quality in major infertility journals. Fertil Steril 2012;98:1539-43.
32. Glujovsky D, Blake D, Farquhar C, Bardach A. Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology. Cochrane Database Syst Rev 2012;7:CD002118.
33. Ciapponi A, Bardach A, Rey Ares L, Glujovsky D, Cafferata ML, Romano M, Cesaroni S, Aikant B. Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis (Protocolo aprobado. Actualmente realizando la revisión). Neuromuscular Disease Group – Cochrane Collaboration
34. Gentile A, Bardach A, Ciapponi A, Garcia-Marti S, Aruj P, Glujovsky D et al. Epidemiology of community-acquired pneumonia in children of Latin America and the Caribbean: a systematic review and meta-analysis. JT – International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2012;16:e5-15.
35. Linhares AC, Stupka JA, Ciapponi A, Bardach AE, Glujovsky D, Aruj PK et al. Burden and typing of rotavirus group A in Latin America and the Caribbean: systematic review and meta-analysis. Rev Med Virol 2011;21:89-109.
36. Glujovsky D, Dominguez M, Fiszbajn G, Papier S, Lavolpe M, Sueldo C. A shared egg donor program: which is the minimum number of oocytes to be allocated? J Assist Reprod Genet 2011;28:263-7.
37. Ciapponi A, Bardach A, Glujovsky D, Gibbons L, Picconi MA. Type-specific HPV prevalence in cervical cancer and high-grade lesions in Latin America and the Caribbean: systematic review and meta-analysis. PLoS One 2011;6:e25493.
38. Bardach A, Ciapponi A, Garcia-Marti S, Glujovsky D, Mazzoni A, Fayad A et al. Epidemiology of acute otitis media in children of Latin America and the Caribbean: a systematic review and meta-analysis. Int J Pediatr Otorhinolaryngol 2011;75:1062-70.
39. Glujovsky D, Pesce R, Fiszbajn G, Sueldo C, Hart RJ, Ciapponi A. Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes. Cochrane Database Syst Rev 2010:CD006359.
40. Glujovsky D, Shamonki MI, Bergh PA. Embryonic synergism may reduce pregnancy loss: a multivariate regression analysis. Fertil Steril 2007;87:509-14.
41. Glujovsky D, Fiszbajn G, Lipowicz R, Lavolpe M, Sueldo C. Practice of sharing donated oocytes among several recipients. Fertil Steril 2006;86:1786-8.
42. Leguizamon G, Krupitzki H, Glujovsky D, Olivera Ravasi M, Reece EA. Blood glucose monitoring in gestational diabetes mellitus: 1- versus 2-h blood glucose determinations. J Matern Fetal Neonatal Med 2002;12:384-8.

Actividad científica

2023 a la actualidad
-Director científico de Cegyr (Eugin group)

2019 a la actualidad
-Miembro del Comité Científico del Grupo (GSC) en Eugin

2017 a la actualidad
-Asesor clínico de Cochrane Clinical Answers (Respuestas Clínicas Cochrane)

2004 a la actualidad
-Editor y revisor en el  Cochrane Gynaecology and Fertility Group

-Investigador de Instituto de Efectividad Clínica y Sanitaria (IECS)
-Miembro del equipo de evaluación de tecnologías sanitarias
-Miembro del equipo de revisiones sistemáticas y evaluaciones económicas

2014 a la actualidad
-Miembro del grupo desarrollador de Covidence (herramienta para las revisiones sistemáticas)
-Revisor en múltiples revistas revisadas por pares

Formación científica

2011
-Taller “Metanálisis con STATA”. Curso Centro Cochrane Iberoamericano. Madrid, España.

2010
-Taller “Como escribir y Publicar un trabajo de investigación – Técnicas y habilidades para sortear las barreras para publicar en inglés”. Dictado por editor de BMJ.

2006
-Curso de postgrado de Revisiones Sistemáticas y Meta-análisis. IECS (Instituto de Efectividad Clínica y Sanitaria)

2004
-Curso de Monitoreo de Ensayos Clínicos. Fundación de Estudios Farmacológicos y de Medicamentos «Prof. Luis M. Zieher»

2003-04
-Master en efectividad clínica. Programa de Efectividad Clínica (PEC). Universidad de Buenos Aires, Hospital Italiano, Harvard School of Public Health y Organización Panamericana de la Salud (OPS)

2002
-Curso de Metodología de la Investigación. Sociedad Argentina de Esterilidad y Fertilidad (SAEF)

2001
-Curso de Medicina Basada en la Evidencia en atención ambulatoria. CEMIC.

Participación en reuniones científicas internacionales

2023
-ESHRE annual meeting. Copenhague, Dinamarca

-Cochrane Colloquium. Londres, Reino Unido.

2022
-ASRM annual meeting. Anaheim, California, Estados Unidos

2021
-ASRM annual meeting. Baltimore, Maryland, Estados Unidos

2019
-ESHRE annual meeting. Viena, Austria

2018
-Cochrane Colloquium. Edimburgo, Escocia.

2017
-Cochrane Colloquium. Using evidence. Improving lives. Ciudad de Cabo, Sudáfrica.

-ASRM annual meeting. San Antonio, Texas, USA.
-Mid-term Ibero-American Cochrane meeting. Medellín, Colombia.

2016
-Cochrane Colloquium. Challenges to evidence-based health care and Cochrane. Seúl, Corea del Sur.
-ASRM annual meeting. Salt Lake City, Utah, USA.
-Cochrane Gynaecology and Fertility Group meeting. Trusted evidence. Informed decisions. Better health. Oxford, Reino Unido.

2015
-ASRM annual meeting. Baltimore, Maryland, USA.
-XXIII Cochrane Colloquium. Filtering the information overload for better decisions. Viena, Austria.
– Mid-term Ibero-American Cochrane meeting. Montevideo, Uruguay

2014      
-ASRM annual meeting. Honolulu, Hawaii, USA
-XXII Cochrane Colloquium. Evidence-informed public health: opportunities and challenges. Hyderabad, India

2013      
-ASRM annual meeting. Boston, Massachusetts, USA
-XXI Cochrane Colloquium. Quebec, Canada.

2012
-XX Cochrane Colloquium. Auckland, Nueva Zelanda

2011
-XIX Cochrane Colloquium. Scientific Evidence for Healthcare Quality and Patient Safety. Madrid, España.

2010
-XVIII Cochrane Colloquium. The Joint Colloquium of the Cochrane & Campbell Collaborations. Keystone Resort, Colorado, USA

2009
-Workshop Internacional de Reproducción Asistida. Red Latinoamericana de Reproducción Asistida. Sociedad Argentina de Medicina Reproductiva (SAMeR). Buenos Aires, Argentina

2008
-Reunión conjunta: Avances y controversias en Reproducción Asistida. “A treinta años del primer nacimiento por Fecundación in Vitro”. VII Tribuna Magistral de CEGYR. Taller Regional de la Red Latinoamericana de Reproducción Asistida

2007
-Taller General de la Red Latinoamericana de Reproducción Asistida. Mar del Plata, Pcia. Buenos Aires, Argentina.

2005
-The Seventh Annual ART of Donor Oocytes and Third Party Reproduction Conference. Charleston, South Carolina, EE.UU.
-NY Metropolitan Embryologist Society Meeting. “PGD for infertility” por Santiago Munne. Weehawken, New Jersey, EE.UU.

Formación académica y títulos

2018
-Programa Ejecutivo de Desarrollo Gerencial – Escuela de negocios de la Universidad Torcuato Di Tella (UTDT), Buenos Aires, Argentina

2017
-Profesional Certificado en Turismo Médico – Medical Tourism Association

2017
-Experto Universitario en Genética Médica – Universidad de Valencia

2009
-Especialista en Medicina Reproductiva. Sociedad Argentina de Medicina Reproductiva – Academia Nacional de Medicina
-Tesis defendida y aprobada “Modelo de predicción de clivaje hasta estadio de blastocisto en embriones de mujeres que realizan tratamiento de reproducción asistida de alta complejidad: score evaluado y validado en 2 cohortes embrionarias”

2003-2004
-Maestría en Efectividad Clínica con orientación en investigación y gestión otorgado por la Facultad de Medicina de la Universidad de Buenos Aires. Programa de Efectividad Clínica (PEC). Universidad de Buenos Aires, Hospital Italiano, Harvard School of Public Health y Organización Panamericana de la Salud (OPS). Mención de Honor al Mejor Promedio.
-Especialización en Reproducción Humana. IFER

1999-2002
-Especialista en Ginecología y Obstetricia. Promedio: 8,56. Instituto Universitario CEMIC

1992-1998
-Médico. Diploma de honor (promedio 8,83). Universidad de Buenos Aires

Capacitación internacional en reproducción asistida

2017 
-Curso de Experto Universitario en Genética Médica – Universidad de Valencia

2013-2017 
-Participación del American Society for Reproductive Medicine (ASRM) annual meeting

2016
-29th Annual In Vitro Fertilization and Embryo Transfer – A Comprehensive Update –UC San Diego School of Medicine. Coronado, California, EE.UU.

2013
-26th Annual In Vitro Fertilization and Embryo Transfer – A Comprehensive Update –David Geffen School of Medicine at UCLA. Santa Barbara, California, EE.UU.

2005
-Rotación por el Reproductive Medicine Associates (RMA) of New Jersey. Morristown, NJ, EE.UU.
-Rotación por el Center for Women’s Reproductive Care at Columbia University. New York, NY, EE.UU.

Presentación de trabajos de investigación en congresos internacionales

2018 en 26th Cochrane Colloquium. Edimburgo, Escocia

-«Background section at Cochrane reviews: is it supported by systematic reviews?» (oral presentation)

-«Introduction to Covidence – Cochrane’s recommended online tool for review production» (workshop)

-«Description of trials and Systematic Reviews exclusively retrieved by LILACS» (poster)

-«Discussion section at Cochrane reviews: is it supported by systematic reviews?» (poster)

-«Do Cochrane systematic reviews report results integrating certainty of evidence and effect size?» (oral presentation)

-«Overlapping of indexed trials and systematic reviews over time among Embase, PubMed, Cochrane Library and LILACS» (poster)

2017 en 25th Cochrane Colloquium. Ciudad del Cabo, Sudáfrica
-“Survey among IVF professionals to assist the development of a decision aid in reproductive medicine” (poster presentation)

-“Burden of disease vs. RCTs in the Southern cone of Latin America ” (oral presentation)

-“Comparison of trends in study designs types in LILACS and PubMed in the last decade” (poster presentation)

-“Conduct and dissemination of epidemiological systematic reviews in Latin America and the Caribbean: Pitfalls and lessons learned” (poster presentation)

-“Optimising rapid-review production: New search filter to identify simultaneously systematic reviews, guidelines, health-technology assessments and RCTs in PubMed” (poster presentation)

-“Overlapping of trials and systematic reviews between LILACS and PubMed” (oral presentation)

2016 en 24th Cochrane Colloquium. Seúl, Corea del Sur
-“Shared decision making and decision aids in MEDLINE” (poster presentation)

2015 en 71^st annual meeting of ASRM 2015. Baltimore, EE.UU.
-“Misleading reporting in major fertility journals: poor use of confidence intervals and absolute differences” (poster presentation)

2015 en 23rd Cochrane Colloquium. Viena, Austria
-“Are 3 days enough to capture the key evidence for HTA documents?” (oral presentation)
-“Fewer randomized controlled trials in fertility and gynecology field: why is this happening?” (poster presentation)
-“Misleading reporting in major fertility journals: poor use of confidence intervals and absolute differences” (poster presentation)
-“Progress of PROSPERO registering systematic reviews” (poster presentation)
-“Connecting with others willing to help: the Project Transform task exchange platform” (workshop)
-“Covidence: Cochrane’s new online tool for review production” (workshop)
-“How can we ensure high quality, up-to-date Cochrane Reviews? The Project Transform production models pilot” (workshop)

2015 en Mid-term Ibero-American Cochrane meeting. Montevideo, Uruguay
-Información engañosa en las principales revistas de fertilidad: escasa utilización de intervalos de confianza y diferencias absolutas. (oral)
-¿Son tres días suficientes para captar la evidencia clave en los documentos de Evaluación de Tecnologías Sanitarias? (oral)
– Progreso del registro PROSPERO para revisiones sistemáticas. (Poster)
– ¿Menos ensayos controlados aleatorizados en el campo de la fertilidad y la ginecología? (Poster)

2014 en 22nd Cochrane Colloquium. Hyderabad, India
-“Adherence to reporting guidelines in biomedical journals of Latin America” (poster presentation)
– “Assessment of reporting quality in infertility journals” (poster presentation)
– “Potentially misleading reporting of comparisons in Cochrane systematic reviews and in major general medical journals” (poster presentation)
-“Effectiveness searching of Lilacs database for systematic review” (workshop)
– “Streamlining your review using Covidence” (workshop)

2013 en 69^th annual meeting of ASRM. Boston, EE.UU.
– “Effect of body mass index on aneuploidy” (poster presentation)

2013 en 21st Cochrane Colloquium. Quebec, Canadá
-“EROS dialogues with RevMan Data Extraction, Quality Assessment and more”
-“The growing trend of indirect comparisons meta-analyses topic appearance in medical literature”
Ciapponi A, Glujovsky D, Bardach A, Garcia Marti S, Comande D
-“MAPA: a live meta-analysis with customized tables in a live map”
-“Effectiveness searching of Lilacs database for systematic review” (workshop)
-“Network meta-analysis in Health Technology Assessments: how frequently used and how necessary are they?”
-“Usefulness of Cochrane Systematic Reviews in Health Technology Assessments in Argentina”

2013 en HTAi 10th Annual Meeting. Seul, Korea
-“Health technology assessment report for positron emission tomography in patients with cancer” (Podium presentation)

2012 en 20th Cochrane Colloquium. Auckland, New Zealand
-“Effective searching of LILACS database for systematic reviews” (workshop)
-“Assessment of research quality in major infertility journals” (poster presentation)
-“Survey among Cochrane authors about early stages of systematic reviews” (poster presentation)
-“Identification of systematic reviews in LILACS” (poster presentation)
– “Risk difference estimation and reporting in systematic reviews” (poster presentation)
-“Reporting, handling, and judging risk of bias associated with missing participant data in systematic reviews” (oral presentation)
-“Subgroup analyses in systematic reviews: A survey of Cochrane and non-Cochrane reviews” (poster presentation)
-“Reporting of absolute estimates of effect of patient important benefits and harms in abstracts of Cochrane and non-Cochrane systematic reviews” (poster presentation)

2011 en XIX Cochrane Colloquium. Scientific Evidence for Healthcare Quality and Patient Safety. Madrid, España
-“Effective searching of LILACS database for systematic reviews” (workshop)
-“EROS: is it the web-based software developed to facilitate the initial phases of a Cochrane systematic review?” (meeting)
-“Using a collaborative online platform to identify systematic reviews in LILACS” (poster)
-“Characteristics of randomized controlled trials (RCT) published in Latin America and the Caribbean’s (LAC) in 2010” (poster)
-“Characteristics of randomized controlled trials published in Latin America and the Caribbean’s in 2010: a cross sectional study” (poster)
-“How evidence-based are the pharmaceutical industry’s printed promotional material presented to physicians in three Latin American countries” (poster)
-“Testing selective responses of Cochrane groups to the request of conducting a systematic review: A Crossover Randomized Controlled Trial” (oral)
-“Absolute risk reduction estimation and reporting in systematic reviews” (poster)
Alonso P, Neumann I, Glujovsky D, y col
-“Feasibility of fast track systematic review for policy makers: interchangeability between pneumococcal conjugate vaccines” (poster)
-“Relación tabaco e ingreso económico: una revisión sistemática y meta-análisis.” (poster)
-“Esquema secuencial VPI/VPO contra la poliomielitis: Revisión Sistemática y Meta-análisis.” (oral)

2011 en ISPOR 3rd Latin America Conference. Mexico DF, Mexico
-“A New Software for Early Stage of Systematic Reviews” (poster)

2011 en Annual meeting HTAi. Rio de Janeiro, Brasil
-“A New Software for Early Stage of Systematic Reviews” (oral)

2010 en XVIII Cochrane Colloquium. The Joint Colloquium of the Cochrane & Campbell Collaborations. Keystone Resort, Colorado, USA
-“How evidence-based are the pharmaceutical industry’s printed promotional material presented to physicians: a multinational study” (oral)
-“New Software for Early Stage of Systematic Reviews” (poster)

2009 en 65th annual meeting of ASRM 2009. Atlanta, EE.UU.
-“Allocating a minimum of 4 metaphase II oocytes has good reproductive outcome in a shared egg donor program” (poster)

2009 en ISPOR 2nd Latin America Conference. Río de Janeiro, Brasil
-“Tobacco and income level: a systematic review and meta-analysis” (poster)

2008 en 64th annual meeting of ASRM. San Francisco, EE.UU.
-“Is it worth testing for AMH in young oocyte donors?” (poster)
-“A randomized prospective comparison between hMG and recombinant FSH in voluntary oocyte donors.” (poster)

2007 en 63th annual meeting of ASRM. Washington, EE.UU.
-“Formula Predicting Progression to Blastocyst Using Characteristics From the First Three Days of Development of 34,708 Embryos” (oral presentation)
-“Day- 3 Embryo Morphology and Progression to Blastocyst: An Analysis of 34,708 Embryos” (poster)
-“The Number of Blastomeres on Day- 2 and the Progression to Blastocyst: An Analysis of 34,883 Embryos” (poster)
-“Estradiol levels after human chorionic gonadotropin (hCG) administration are not predictive of IVF outcome: analysis of 7,474 initial fresh IVF cycles” (poster)
-“Length of time of estrogen administration in recipients does not reduce implantation rates in an oocyte donation program” (poster)
-“High ovarian response does not affect oocyte quality: a model based on sharing donated oocytes” (poster)

2006 en 62nd annual meeting of ASRM. New Orleans, EE.UU.
-“The practice of sharing donated oocytes among several recipients” (poster)
-“Assessment of motivations, attitudes and psychosocial features among voluntary oocyte donors in Argentina” (oral)
-“Pregnancy complications among ART patients that conceived with their own oocytes or through oocyte donation” (poster)

2005 en ESHRE annual meeting. Copenhague, Dinamarca
-“Bad quality embryos: Give them a chance with good transfer technique” (póster)